BC Platforms

OverviewSuggest Edit

BC Platforms provides powerful genomic data management and analysis solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies.
The Company's high performing genomic data management platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information.
BC Platforms’ vision is to revolutionize decision making in drug development to bring clinical benefits to patients.

TypePrivate
Founded1997
HQZürich, CH
Websitebcplatforms.com

Latest Updates

Employees (est.) (Oct 2020)66(-1%)
Cybersecurity ratingBMore

Key People/Management at BC Platforms

Richard Kivel

Richard Kivel

Chairman of the Board
Tom Gibbs

Tom Gibbs

Board Member
Jari Heikkinen

Jari Heikkinen

Board Member
Tero Silvola

Tero Silvola

CEO
Show more

BC Platforms Office Locations

BC Platforms has offices in Zürich, Boston and Espoo
Zürich, CH (HQ)
Bleicherweg 10
Espoo, FI
Vaisalantie 2-8
Boston, US
51 Melcher St
Show all (3)

BC Platforms Financials and Metrics

Summary Metrics

Founding Date

1997

BC Platforms total Funding

$25 m

BC Platforms latest funding size

$15 m

Time since last funding

10 months ago

BC Platforms investors

BC Platforms's latest funding round in December 2019 was reported to be $15 m. In total, BC Platforms has raised $25 m
Show all financial metrics

BC Platforms Operating Metrics

Dec, 2019

Countries Covered

25

Partners (Health and Wellness)

100
Show all operating metrics

BC Platforms Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

BC Platforms Online and Social Media Presence

Embed Graph

BC Platforms News and Updates

World's Leading Biobanks Join BC Platforms Global Data Partner Network to Advance Personalized Healthcare Research

ZURICH and BOSTON, April 6, 2020 /PRNewswire/ -- BC Platforms, a global leader in providing a powerful data and technology platform for personalized healthcare, today announced it has added three new leading biobanks to its Global Data Partner Network, BCRQUEST.com, including Generation...

BC Platforms Partners with Dante Labs to Build Europe's Largest Next Generation Sequencing Laboratory for Private and Public Customers

ZURICH and BOSTON, Jan. 8, 2020 /PRNewswire/ -- BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and...

BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics

BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™ (NYSE: IQV). The round was led by IQVIA in conjunction with Debiopharm Innovation Fund and Tesi, a Finnish …

BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe

ZURICH and BOSTON, Dec. 6, 2019 /PRNewswire/ -- BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Life & Brain Genomics, a division of Life & Brain GmbH. Life & Brain Genomics is one of the leading European servic…

BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine

ZURICH and BOSTON, Nov. 7, 2019 /PRNewswire/ -- BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, today announced that has established a Singapore-based entity in order to spearhead its activities in the Asia Pacific region, including China....

BC Platforms Provides Complete Data Management Solution for Debiopharm's Oncology Development Portfolio

ZURICH and BOSTON, Sept. 9, 2019 /PRNewswire/ -- BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Debiopharm, a Swiss pharmaceutical company, to deliver a complete clinical and genomic data management solution...
Show more

BC Platforms Blogs

Large scale genomic data production with an automated and streamlined system

The post Large scale genomic data production with an automated and streamlined system appeared first on BC Platforms.

Sourcing COVID-19 Patient Data for Drug Development

Does access to data on 30,000 COVID-19 patients make a difference in the race against this pandemic? It all depends on how this data is applied, especially in the research context. Through BC Platforms’ Global Data Partner Network, we provide access to this valuable, uniquely curated diverse data co…

Sourcing Global COVID-19 Patient Data for Drug Development

Does access to data on 30,000 COVID-19 patients make a difference in the race against this pandemic? It all depends on how this data is applied, especially in the research context. Through BC Platforms’ Global Data Partner Network, we provide access to this valuable, uniquely curated diverse data co…

Establishing an End-to-End Personalised Healthcare Framework

To address a growing need for personalized care, a large healthcare organization in Colorado established a precision medicine center, consisting of a hospital biobank which integrated 6 million patient records to leverage existing data and begin looking at healthcare on an individual level. After a …

Massively Parallel Multi-Chip Imputation Pipeline Based on Novel Genomic Tiling Technology

One of largest genetic testing companies in the US is leading a streamlined operation to produce large volumes of genomic data for pharma and DTC customers with diverse needs. Their goal is to be extremely operationally and technically efficient. In order to achieve this, they needed to massively sc…

Enhancing Early Target Discovery

Situation A leading pharmaceutical company received the UK Biobank cohort with a large amount (n= 500,000) of phenotypic data in support of target discovery on a deeper level. Company researchers sought to explore the UK Biobank dataset at scale, building complex queries that take multiple parameter…
Show more

BC Platforms Frequently Asked Questions

  • When was BC Platforms founded?

    BC Platforms was founded in 1997.

  • Who are BC Platforms key executives?

    BC Platforms's key executives are Richard Kivel, Tom Gibbs and Jari Heikkinen.

  • How many employees does BC Platforms have?

    BC Platforms has 66 employees.

  • Who are BC Platforms competitors?

    Competitors of BC Platforms include PHEMI Systems, Verily Life Sciences and GenoLogics.

  • Where is BC Platforms headquarters?

    BC Platforms headquarters is located at Bleicherweg 10, Zürich.

  • Where are BC Platforms offices?

    BC Platforms has offices in Zürich, Boston and Espoo.

  • How many offices does BC Platforms have?

    BC Platforms has 3 offices.